AL Amyloidosis (Amyloidosis Antibody Light). Part 1. Definition, Classification, Amyloid Structure, Development and Etiopathogenesis of AL Amyloidosis

被引:0
|
作者
Usnarska-Zubkiewicz, Lidia [1 ]
Holojda, Jadwiga [2 ]
Kuliczkowski, Kazimierz [1 ]
机构
[1] Wroclaw Med Univ, Dept Hematol Blood Neoplasms & Bone Marrow Transp, PL-50367 Wroclaw, Poland
[2] Dist Specialist Hosp Legnica, Dept Hematol, Legnica, Poland
来源
关键词
amyloidosis AL; classification; amyloid structure; etiopathogenesis; PRIMARY SYSTEMIC AMYLOIDOSIS; ORGAN INVOLVEMENT; GENE USE; CHAINS; ASSOCIATION; SURVIVAL; TRANSLOCATIONS; PROTEINS; CELLS;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Amyloidosis is an inherited or acquired systemic storage disease in which a pathologic, amorphous substance produced as a result of abnormal protein metabolism and resistant to proteolysis is deposited in the extracellular space of various tissues (intracellular deposits occur rarely). This leads to the destruction of normal tissue architecture and disturbs its function. The development of amyloidosis is associated with the transformation of the alpha-spiral conformation of fibrous protein into a stratified, parallel, folded spatial beta-conformation. The transition of the fibrous proteins conformation and their tissue localization causes resistance of the fibers to proteolytic processes as a result of a limited access of the protein converting enzymes. In this paper we show the actual classification of amyloidosis and up-to-date knowledge about the amyloid structure, development and etiopathogenesis of AL amyloidosis (Adv Clin Exp Med 2011, 20, 5, 647-652).
引用
收藏
页码:647 / 652
页数:6
相关论文
共 50 条
  • [41] Preclinical development of siRNA therapeutics for AL amyloidosis
    B M Hovey
    J E Ward
    P Soo Hoo
    C J O'Hara
    L H Connors
    D C Seldin
    [J]. Gene Therapy, 2011, 18 : 1150 - 1156
  • [42] Stabilization of amyloidogenic antibody light chains as a potential therapeutic strategy in AL amyloidosis
    Morgan, Gareth
    Yan, Nicholas
    Kelly, Jeffery
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E326 - E326
  • [43] Occurrence of prostaglandin D synthase in urine of patients with immunoglobulin light chain amyloidosis (AL amyloidosis)
    Murphy, C
    Niewold, T
    Solomon, A
    [J]. PROSTAGLANDINS, 1996, 51 (04): : 291 - 291
  • [44] Frequency of hereditary systemic amyloidosis masquerading as immunoglobulin light chain, AL (primary), amyloidosis.
    Lachmann, HJ
    Booth, DR
    Bybee, A
    Gillmore, JD
    Hawkins, PN
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 39A - 39A
  • [45] Regression of gastroduodenal amyloid deposits after chemotherapies in AL amyloidosis
    Katoh, N.
    Tsuchiya-Suzuki, A.
    Matsuda, M.
    Ikeda, S.
    [J]. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2010, 17 : 202 - 202
  • [46] Radio-immunodetection of amyloid deposits in patients with AL Amyloidosis?
    Saada, Veronique
    [J]. HEMATOLOGIE, 2010, 16 (03): : 187 - 188
  • [47] Radio-immunodetection of amyloid deposits in patients with AL Amyloidosis
    Manier, Salomon
    Leleu, Xavier
    [J]. HEMATOLOGIE, 2010, 16 (04): : 271 - 272
  • [48] Producing amyloid fibrils in vitro: A tool for studying AL amyloidosis
    Sizova, Daria, V
    Raiker, Steve
    Lakheram, Deaneira
    Rao, Vishwanatha
    Proffitt, Andrew
    Jmeian, Yazen
    Voegtli, Walter
    Batonick, Melissa
    [J]. BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2023, 34
  • [49] Amyloid deposits in the bone marrow in patients with AL amyloidosis.
    Scaramucci, L
    Niscola, P
    Ciafrino, R
    Morucci, M
    Montanaro, M
    [J]. BLOOD, 2003, 102 (11) : 365B - 365B
  • [50] Clonal hematopoiesis of indeterminate potential (CHIP) in patients with amyloid light chain (AL) amyloidosis
    Lopedote, Paolo
    Marchetti, Alfredo
    Evans, Benjamin
    Miller, Shannon
    Chen, Tianzeng
    Moscvin, Maria
    Bolli, Niccolo'
    Bianchi, Giada
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S281 - S281